retatrutide clinical trial results weight loss retatrutide trials New Phase 3 data just dropped 👀 Eli Lilly's retatrutide clinical trial results weight

No significant difference was observed between the two groups in terms of stress levels (P = 0.295), which were not significant after adjustment ( P = 0.316)

Tissue-level pharmacology has been characterised across the major target organs

In patients with Crohns disease (CD) and ulcerative colitis (UC), higher amounts of Escherichia coli have been observed pointing to the possibility that administration of PPIs would further induce these infections (Bruno et al

60 Be mindful of portion sizes and don't feel obligated to finish everything

The short answer: yes, but your health profile and digestive changes require careful evaluation

Lulich JP, Osborne CA, OBrien TD, et al